1. Home
  2. WLDS vs ENTO Comparison

WLDS vs ENTO Comparison

Compare WLDS & ENTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLDS
  • ENTO
  • Stock Information
  • Founded
  • WLDS 2014
  • ENTO 2014
  • Country
  • WLDS Israel
  • ENTO United States
  • Employees
  • WLDS N/A
  • ENTO N/A
  • Industry
  • WLDS Computer Communications Equipment
  • ENTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • WLDS Telecommunications
  • ENTO Health Care
  • Exchange
  • WLDS Nasdaq
  • ENTO Nasdaq
  • Market Cap
  • WLDS 2.0M
  • ENTO 2.3M
  • IPO Year
  • WLDS 2022
  • ENTO 2016
  • Fundamental
  • Price
  • WLDS $1.43
  • ENTO $0.37
  • Analyst Decision
  • WLDS
  • ENTO
  • Analyst Count
  • WLDS 0
  • ENTO 0
  • Target Price
  • WLDS N/A
  • ENTO N/A
  • AVG Volume (30 Days)
  • WLDS 544.5K
  • ENTO 852.3K
  • Earning Date
  • WLDS 01-01-0001
  • ENTO 05-15-2025
  • Dividend Yield
  • WLDS N/A
  • ENTO N/A
  • EPS Growth
  • WLDS N/A
  • ENTO N/A
  • EPS
  • WLDS N/A
  • ENTO N/A
  • Revenue
  • WLDS $522,000.00
  • ENTO N/A
  • Revenue This Year
  • WLDS N/A
  • ENTO N/A
  • Revenue Next Year
  • WLDS N/A
  • ENTO N/A
  • P/E Ratio
  • WLDS N/A
  • ENTO N/A
  • Revenue Growth
  • WLDS 536.59
  • ENTO N/A
  • 52 Week Low
  • WLDS $1.20
  • ENTO $0.19
  • 52 Week High
  • WLDS $48.80
  • ENTO $1.54
  • Technical
  • Relative Strength Index (RSI)
  • WLDS 46.69
  • ENTO 44.28
  • Support Level
  • WLDS $1.38
  • ENTO $0.45
  • Resistance Level
  • WLDS $2.18
  • ENTO $0.57
  • Average True Range (ATR)
  • WLDS 0.18
  • ENTO 0.07
  • MACD
  • WLDS 0.00
  • ENTO -0.01
  • Stochastic Oscillator
  • WLDS 18.75
  • ENTO 3.77

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

About ENTO Entero Therapeutics Inc. Common Stock

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: